Viewing Study NCT01381432


Ignite Creation Date: 2025-12-24 @ 9:28 PM
Ignite Modification Date: 2025-12-29 @ 10:39 AM
Study NCT ID: NCT01381432
Status: COMPLETED
Last Update Posted: 2013-05-13
First Post: 2011-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)
Sponsor: GlaxoSmithKline
Organization:

Study Overview

Official Title: Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)
Status: COMPLETED
Status Verified Date: 2013-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This post-marketing surveillance study is to investigate the efficacy and safety of azathioprine tablets in subjects whom lung transplantation is performed.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: